Wells Fargo and Barclays Reassess Oscar Health Amid Rising Medical Costs for 2025

Wells Fargo and Barclays have issued negative outlooks for Oscar Health (NYSE: OSCR), citing concerns over escalating medical costs and insufficient pricing strategies for 2025. The financial analysis underscores potential challenges in maintaining profitability amid rising healthcare expenses. These assessments suggest that Oscar Health's current pricing models may need reassessment to address financial sustainability.